Aspirin is Effective But a Risky Form of Cancer Prevention

While aspirin daily use has benefits, it has risks as well.

As a primary method of preventing cancer aspirin is probably too risky to use for prevention.

Studies have shown that regular use of aspirin over a long period of time may reduce the risk of developing certain types of cancer, including colorectal, esophageal, stomach, and ovarian cancer.

In a new study in Korea looking at their National Health Insurance Service data other medicines besides aspirin were shown to help ovarian cancer clients, with better survival after long term beta-blocker use.

Aspirin may prevent colon cancer in the same way aspirin works to prevent painful headaches and menstrual cramps. by reducing inflammation and blocking the production of certain enzymes that contribute to the growth of cancer cells. Aspirin is a type of nonsteroidal anti-inflammatory drug (NSAID), and it works by inhibiting an enzyme called cyclooxygenase-2 (COX-2).

COX-2 is involved in the production of prostaglandins, which are hormones that promote inflammation. Inflammation can damage cells and increase the risk of cancer. By blocking COX-2, aspirin may reduce inflammation in the colon and lower the risk of cancer.

Aspirin may also help prevent colon cancer by inducing cell death in precancerous cells and by preventing the formation of new blood vessels that can nourish tumors.

However, while aspirin may have some protective effects against colon cancer, it is important to note that regular aspirin use can also have side effects and risks, such as gastrointestinal bleeding and an increased risk of stroke.

Therefore, the decision to take aspirin for cancer prevention should be made in consultation with a healthcare professional, weighing the potential benefits and risks for each individual.

Rege